Boletín HCSBA

1.- Toubiana J., Poirault C., Corsia A. et al. Kawasaki-like multisystem inflammatory syndrome in children during the Covid- 19 pandemic in Paris, France: prospective observational study. BMJ. 2020 ; 369 :m 2094 -m 2094. 2.- Whittaker E., Bamford A., Kenny J., et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV- 2 . JAMA. 2020;324(3):259-269. 3.- Verdoni L., Mazza A., Gervasoni A. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV- 2 epidemic: an observational cohort study. Lancet. 2020;395:1771-1778. 4.- Dufort E., Koumans E., Chow E. et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347-358 . 5.- Feldstein L., Rose E., Horwitz S. et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334-346. 6.- European Centre for Disease Prevention and Control. Paediatric inflammatory multisystem syndrome and SARS-CoV- 2 infection in children - 15 May 2020 . ECDC: Stockholm; 2020 . 7.- Centers for Disease Control and Prevention Health Alert Network Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID- 19 ). 2020 ; https://emergency.cdc.gov/han/ 2020 /han 00432 .asp , última visita: 20-08-2020. 8.- World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID- 19 . 2020 ; https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid- 1 9 9.- Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID- 19 pandemic. Lancet. 2020;395:1607-1608. 10.- Torres J., Izquierdo G., Acuña M. et al. Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV- 2 pandemic. Pre-Proof. IJID. https://doi.org/ 1 0.1016 /j.ijid. 2020.08.062 11.- Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID- 19 pandemic. Lancet. 2020 . 12.- Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID- 19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38:1---9.0;395:1607-1608 . 13.- García-Salido A. Revisión Narrativa Sobre La Respuesta Inmunitaria Frente A Coronavirus: Descripción General, Aplicabilidad Para SARS-CoV- 2 e Implicaciones Terapéuticas, Anales de Pediatría ( 2020 ). https://doi.org/ 1 0.1016 /j.anpedi. 2020.04.016 14.- Belhadjer Z., Méot M., Bajolle F. et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV- 2 pandemic. Circulation. 2020;142:429-436 . 15.- Blondiaux E., Parisot P., Redheuil A., Tzaroukian L., Levy Y., et al. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID- 19 : Case Series. Radiology 2020 ; 297 :E 283 -E 288 . doi.org/ 1 0.1148 /radiol. 2020202288 16.- Villanueva M, Faúndez R, Godoy M. Manifestaciones gastrointestinales y hepáticas de COVID- 19 en niños. RevChilPediatr. 2020;91(4):623-630 DOI: 10.32641 / rchped.vi 9 1 i 4.2484 . 17.- Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J ThrombHaemost 2020; 18: 844-47 . 18.- Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID- 19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J ThrombHaemost 2020 ; published online April 17 . https://doi.org/ 1 0.1111 /jth. 14850 19.- Goshua G., Pine A., Meizlish M., Chang C., Zhang H. Endotheliopathy in COVID- 19 -associated coagulopathy: evidence from a single-centre, cross-sectional study. The Lancet 2020 . doi.org/ 1 0.1016 /S 2352 - 3026 ( 20 ) 30216 - 7 20.- Quiroz V, Amarales Compromiso neurológico en infección por COVID- 19 en pacientes pediátricos. Rev Chil Pediatr. 2020 ; 91 ( 4 ): 614 619 .DOI: 10.32641 /rchped. vi 91 i 4 . 2526 . Bibliografía: 13 marzo 2021. Volumen 20 - N ° 79